Blood Sugar & Glucose Diary
Blood Sugar & Glucose Diary is a health-tracking app for manual glucose, insulin, and medication logging on iOS.
The App DNA
What makes this app unique?
The app removes the cognitive friction of paper-based diabetes logs by providing a centralized, secure digital history for clinical appointments.
For Individuals managing Type 1, Type 2, or prediabetes who require a digital logbook for tracking glucose, insulin, and medication.
What does it look like?
Key features
Manual entry of glucose readings and medication usage; core utility loop driving daily app interaction.
Calculates long-term control metrics; premium-tier gate incentivizing subscription conversion.
Configurable push notifications; retention lever forcing daily app interaction.
Professional data portability; premium-tier gate targeting users with frequent doctor visits.
How much does it cost?
Freemium model using feature-gating to restrict advanced analytical tools and ad-free access to paying subscribers.
Velocity
Maintenance developmentUX improvementsShow more...
The app currently operates at a maintenance cadence, with only one release shipped in the last 100 days. Development is limited to minor UI adjustments and the addition of basic utility features. There is no evidence of a recurring live operations strategy or frequent feature iteration. The current pace suggests a focus on long-term stability rather than active growth.
Who built it?
User Sentiment
What do users think recently?
How are ratings & reviews evolving?
Not enough recent reviews to extract reliable themes yet.
Read the full review analysisCompetition
Competitive landscape for Blood Sugar & Glucose Diary
How's the Health & Fitness market?
Blood Sugar & Glucose Diary occupies a niche in the Health & Fitness category as a manual-entry tracker. The 100-day update gap signals a maintenance-only posture, contrasting with the high-frequency release cycles of automated health-monitoring rivals.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for Blood Sugar & Glucose Diary
Where is it heading?
The health-tracking market is shifting toward automated, hardware-integrated data collection, leaving manual-entry apps like Blood Sugar & Glucose Diary in a defensive position. Without a roadmap for CGM integration, the app risks becoming a legacy tool for a shrinking segment of users who prefer manual logging.
- The 100-day update gap indicates a maintenance-only posture, which erodes competitive relevance against high-frequency health-tech rivals.
- Manual-entry logging remains a stable utility for prediabetic users who do not require the complexity of continuous glucose monitoring.
The SWOT
- Lightweight interface reduces logging friction
- Ad-free premium tier captures users fleeing ad-heavy rivals
Next best moves
Ship CGM integration because manual entry is a high-friction barrier for T1D users → increase daily active usage
+ 1 more prioritized moveThe counter-intuitive read
The app's lack of hardware integration is a feature, not a bug…
Read the full takeSince the last report: The app's competitive positioning has shifted from a neutral logbook utility to a defensive manual-entry tool, with a new strategic focus on hardware integration to address T1D user needs.
Bottom line
Blood Sugar & Glucose Diary provides a stable manual-entry log, but the 100-day development gap leaves it vulnerable to automated health platforms. Pivoting to hardware integration would unlock the T1D segment, which currently finds manual logging insufficient for modern diabetes management.
Unlock 1 critical friction, 1 market threat, 1 more prioritized move and the analyst’s take.
Access the full report for freeSources
- [1] App Store
Report last updated